Time required for navigated macular laser photocoagulation treatment with the Navilas®
- 7 August 2012
- journal article
- research article
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 251 (4) , 1049-1053
Abstract
Navilas® laser is a novel technology combining photocoagulation with imaging, including fluorescein angiographic (FA) images which are annotated and aligned to a live fundus view. We determine the time necessary for planning and treatment of macular edema utilizing the Navilas®. The screen recordings during treatments were retrospectively analyzed for treatment type, number of laser shots, the duration of planning (measured from the time the planning image was selected to time of marking the last planned treatment spot), and total time of laser application. A total of 93 treatments (30 grid, 30 focal and 33 combined treatments) by four physicians from three sites were included. An average of 125 spots were applied to each eye. The total time spent for each focal treatment - including the planning was 7 min 47 s (±3 min and 32 s). Navilas® is a novel device providing a time efficient platform for evaluating FA images and performing threshold macular laser photocoagulation.Keywords
This publication has 17 references indexed in Scilit:
- FOCAL NAVIGATED LASER PHOTOCOAGULATION IN RETINOVASCULAR DISEASERetina, 2012
- Ranibizumab for Macular Edema Due to Retinal Vein OcclusionsOphthalmology, 2012
- Does Laser Still Have a Role in the Management of Retinal Vascular and Neovascular Diseases?American Journal of Ophthalmology, 2011
- Clinical Evaluation and Treatment Accuracy in Diabetic Macular Edema Using Navigated Laser Photocoagulator NAVILASOphthalmology, 2011
- Expanded 2-Year Follow-up of Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular EdemaOphthalmology, 2011
- Two-Year Outcomes of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) StudyOphthalmology, 2010
- Focal and panretinal photocoagulation with a navigated laser (NAVILAS®)Acta Ophthalmologica, 2010
- Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular EdemaOphthalmology, 2010
- A Randomized Trial Comparing the Efficacy and Safety of Intravitreal Triamcinolone With Observation to Treat Vision Loss Associated With Macular Edema Secondary to Central Retinal Vein OcclusionArchives of Ophthalmology (1950), 2009
- A Randomized Trial Comparing the Efficacy and Safety of Intravitreal Triamcinolone With Standard Care to Treat Vision Loss Associated With Macular Edema Secondary to Branch Retinal Vein OcclusionArchives of Ophthalmology (1950), 2009